Figure 4.
Forest plots and funnel plots for microbiological response between colistin monotherapy and colistin plus meropenem combination therapy. Five studies involving 655 patients (285 with colistin monotherapy, 370 with colistin plus meropenem combination therapy) reported the microbiological response. The overall microbiological response was significantly different between the two groups. The combination therapy patient group had a better microbiological response than the monotherapy patient group [24,25,28,31,32].
